US begins study on allergic reaction risk in Moderna, Pfizer vaccines

A man receives the first dose of Moderna COVID-19 vaccine at a new vaccination mega center in Athens, Friday, April 2, 2021. Greece has announced it is relaxing some coronavirus restrictions despite surging COVID-19 cases that are straining hospitals to their limits, with retail stores to reopen and people allowed to drive outside their home municipalities for exercise on weekends. (AP Photo/Thanassis Stavrakis) (AP)
A man receives the first dose of Moderna COVID-19 vaccine at a new vaccination mega center in Athens, Friday, April 2, 2021. Greece has announced it is relaxing some coronavirus restrictions despite surging COVID-19 cases that are straining hospitals to their limits, with retail stores to reopen and people allowed to drive outside their home municipalities for exercise on weekends. (AP Photo/Thanassis Stavrakis) (AP)
Premium
 1 min read . Updated: 07 Apr 2021, 10:03 PM IST Reuters

In January, the US Centers for Disease Control and Prevention said allergic reactions are occurring at a rate of 11.1 per 1 million vaccinations

The US National Institutes of Health said on Wednesday it had begun a mid-stage study to determine the risk of allergic reactions to Covid-19 vaccines made by Moderna Inc and Pfizer Inc.

Several allergic reaction incidents, including serious episodes, known as anaphylaxis, have been reported in the US after vaccinations of Pfizer/BioNTech and Moderna shots.

TRENDING STORIESSee All

Also Read | The dark side of India’s solar gamble

In January, the US Centers for Disease Control and Prevention said allergic reactions are occurring at a rate of 11.1 per 1 million vaccinations.

The study, funded by the National Institute of Allergy and Infectious Diseases, will enroll 3,400 adults between the ages of 18 to 69, with about 60% participants having a history of severe allergic reactions to food, insect stings or immunotherapy.

The goal of the trial is to access the proportion of participants who have a systemic allergic reaction within 90 minutes after injection.

The agency expects to report data later this summer.


This story has been published from a wire agency feed without modifications to the text.

Subscribe to Mint Newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.

Click here to read the Mint ePaperMint is now on Telegram. Join Mint channel in your Telegram and stay updated with the latest business news.

Close